{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:45:39Z","timestamp":1788965139783,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.thromres.2025.109256","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T20:16:37Z","timestamp":1736453797000},"page":"109256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Tissue factor-bearing extracellular vesicles, procoagulant phospholipids and D-dimer as potential biomarkers for venous thromboembolism in patients with newly diagnosed multiple myeloma: A comprehensive analysis"],"prefix":"10.1016","volume":"247","author":[{"given":"S.","family":"Charles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Fatrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Bouriche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bonifay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Lecompte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Dignat-George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Tardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Frere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Chalayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.thromres.2025.109256_bb0005","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2025.109256_bb0010","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1538-7836.2011.04215.x","article-title":"Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis","volume":"9","author":"Carrier","year":"2011","journal-title":"J. Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2025.109256_bb0015","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/jth.15758","article-title":"Prediction of venous thromboembolism in patients with multiple myeloma treated with lenalidomide, bortezomib, dexamethasone, and transplantation: lessons from the substudy of IFM\/DFCI 2009 cohort","volume":"20","author":"Chalayer","year":"2022","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2025.109256_bb0020","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jamaoncol.2016.3350","article-title":"Cardiovascular and thrombotic complications of novel multiple myeloma therapies: a review","volume":"3","author":"Li","year":"2017","journal-title":"JAMA Oncol."},{"issue":"7","key":"10.1016\/j.thromres.2025.109256_bb0025","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/rth2.12411","article-title":"Venous thromboembolism in multiple myeloma is associated with increased mortality","volume":"4","author":"Schoen","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.thromres.2025.109256_bb0030","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.6004\/jnccn.2020.0057","article-title":"Multiple myeloma, version 3.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"18","author":"Kumar","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.thromres.2025.109256_bb0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.thromres.2023.11.021","article-title":"Venous thromboembolism prophylaxis and multiple myeloma patients in real-life: results of a large survey and clinical guidance recommendations from the IFM group","volume":"233","author":"Frenzel","year":"2023","journal-title":"Thromb. Res."},{"issue":"11","key":"10.1016\/j.thromres.2025.109256_bb0040","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/ajh.25603","article-title":"Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score","volume":"94","author":"Sanfilippo","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"7","key":"10.1016\/j.thromres.2025.109256_bb0045","doi-asserted-by":"crossref","first-page":"840","DOI":"10.6004\/jnccn.2018.7273","article-title":"Derivation and validation of a risk assessment model for immunomodulatory drug\u2013associated thrombosis among patients with multiple myeloma","volume":"17","author":"Li","year":"2019","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.thromres.2025.109256_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/JBM.S147743","article-title":"Evaluation of thrombosis-related biomarkers before and after therapy in patients with multiple myeloma","volume":"9","author":"Nomura","year":"2018","journal-title":"J. Blood Med."},{"issue":"Supplement_1","key":"10.1016\/j.thromres.2025.109256_bb0055","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1182\/blood-2019-124650","article-title":"Procoagulant microparticles derived from myeloma plasma cells have a determinant role in the hypercoagulable state associated with multiple myeloma. A modelization in vitro study","volume":"134","author":"Papageorgiou","year":"2019","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.thromres.2025.109256_bb0060","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1111\/jth.15773","article-title":"The role of VWF\/FVIII in thrombosis and cancer progression in multiple myeloma and other hematological malignancies","volume":"20","author":"Comerford","year":"2022","journal-title":"J. Thromb. Haemost. JTH."},{"issue":"12","key":"10.1016\/j.thromres.2025.109256_bb0065","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1080\/10428194.2023.2247513","article-title":"Thrombosis in multiple myeloma: mechanisms, risk assessment and management","volume":"64","author":"Jarchowsky","year":"2023","journal-title":"Leuk. Lymphoma"},{"issue":"6","key":"10.1016\/j.thromres.2025.109256_bb0070","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s11239-024-02977-0","article-title":"Comprehensive evaluation of genetic and acquired thrombophilia markers for an individualized prediction of clinical thrombosis in patients with lymphoma and multiple myeloma","volume":"57","author":"S\u00e1nchez Prieto","year":"2024","journal-title":"J. Thromb. Thrombolysis"},{"issue":"1","key":"10.1016\/j.thromres.2025.109256_bb0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/rth2.12161","article-title":"Thrombin generation in newly diagnosed multiple myeloma during the first three cycles of treatment: an observational cohort study","volume":"3","author":"Chalayer","year":"2018","journal-title":"Res Pract Thromb Haemost."},{"key":"10.1016\/j.thromres.2025.109256_bb0080","article-title":"Patients with multiple myeloma have a disbalanced whole blood thrombin generation profile","volume":"9","author":"Li","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.thromres.2025.109256_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-013-1084-8","article-title":"Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies","volume":"113","author":"Akers","year":"2013","journal-title":"J. Neuro-Oncol."},{"issue":"5","key":"10.1016\/j.thromres.2025.109256_bb0090","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/jth.12554","article-title":"Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration","volume":"12","author":"Arraud","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"13","key":"10.1016\/j.thromres.2025.109256_bb0095","article-title":"Extracellular vesicles enhance multiple myeloma metastatic dissemination","volume":"20","author":"Colombo","year":"2019","journal-title":"Int. J. Mol. Sci. [Internet]"},{"issue":"11","key":"10.1016\/j.thromres.2025.109256_bb0100","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.3390\/cells10113185","article-title":"Role of extracellular vesicle-based cell-to-cell communication in multiple myeloma progression","volume":"10","author":"Saltarella","year":"2021","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.thromres.2025.109256_bb0105","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.3324\/haematol.2021.279716","article-title":"Extracellular vesicles mediate the communication between multiple myeloma and bone marrow microenvironment in a NOTCH dependent way","volume":"107","author":"Giannandrea","year":"2022","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.thromres.2025.109256_bb0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10456-018-9649-y","article-title":"Extracellular vesicles of multiple myeloma cells utilize the proteasome inhibitor mechanism to moderate endothelial angiogenesis","volume":"22","author":"Zarfati","year":"2019","journal-title":"Angiogenesis"},{"key":"10.1016\/j.thromres.2025.109256_bb0115","article-title":"Circulating extracellular vesicles are strongly associated with cardiovascular risk markers","volume":"9","author":"Zhou","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"11","key":"10.1016\/j.thromres.2025.109256_bb0120","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.3390\/ijms20112840","article-title":"Biology and role of extracellular vesicles (EVs) in the pathogenesis of thrombosis","volume":"20","author":"Zar\u00e0","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.thromres.2025.109256_bb0125","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/s41598-018-19889-8","article-title":"Tissue factor-bearing MPs and the risk of venous thrombosis in cancer patients: a meta-analysis","volume":"8","author":"Cui","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.thromres.2025.109256_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210835","article-title":"Extracellular vesicle-associated procoagulant phospholipid and tissue factor activity in multiple myeloma","volume":"14","author":"Nielsen","year":"2019","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.thromres.2025.109256_bb0135","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.jtha.2024.05.037","article-title":"Comparison of assays measuring extracellular vesicle-tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology","volume":"22","author":"Bonifay","year":"2024","journal-title":"J. Thromb. Haemost. JTH."},{"issue":"4","key":"10.1016\/j.thromres.2025.109256_bb0140","article-title":"Challenges with measuring tissue factor antigen and activity in human plasma","volume":"1","author":"Mackman","year":"2024","journal-title":"Blood Vessels Thromb. Hemost."},{"key":"10.1016\/j.thromres.2025.109256_bb0145","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/S0049-3848(16)30103-7","article-title":"Update of thrombosis in multiple myeloma","volume":"140","author":"Leebeek","year":"2016","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2025.109256_bb0150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2020-142762","article-title":"D-dimer improves risk prediction of venous thromboembolism in patients with multiple myeloma","volume":"136","author":"Sanfilippo","year":"2020","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2025.109256_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"issue":"11","key":"10.1016\/j.thromres.2025.109256_bb0160","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1111\/j.1538-7836.2008.03156.x","article-title":"Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer","volume":"6","author":"Khorana","year":"2008","journal-title":"J Thromb Haemost JTH."},{"issue":"7","key":"10.1016\/j.thromres.2025.109256_bb0165","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/leu.2012.43","article-title":"Absence of tissue factor expression by neoplastic plasma cells in multiple myeloma","volume":"26","author":"Cesarman-Maus","year":"2012","journal-title":"Leukemia"},{"issue":"05","key":"10.1016\/j.thromres.2025.109256_bb0170","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1160\/TH07-11-0691","article-title":"Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells","volume":"100","author":"Aharon","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2025.109256_bb0175","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1038\/s41598-017-03159-0","article-title":"Endothelial cell-derived extracellular vesicles size-dependently exert procoagulant activity detected by thromboelastometry","volume":"7","author":"Holnthoner","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.thromres.2025.109256_bb0180","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1160\/TH10-03-0187","article-title":"Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma","volume":"105","author":"Auwerda","year":"2011","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.thromres.2025.109256_bb0185","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.thromres.2021.03.015","article-title":"Prothrombotic abnormalities in patients with multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"202","author":"Nielsen","year":"2021","journal-title":"Thromb Res"},{"issue":"41","key":"10.1016\/j.thromres.2025.109256_bb0190","doi-asserted-by":"crossref","first-page":"26453","DOI":"10.18632\/oncotarget.25458","article-title":"Biomarkers for the risk of thrombosis in pancreatic adenocarcinoma are related to cancer process","volume":"9","author":"Faille","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.thromres.2025.109256_bb0195","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.thromres.2018.04.009","article-title":"Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: a prospective cohort study","volume":"166","author":"Es","year":"2018","journal-title":"Thromb. Res."},{"issue":"8","key":"10.1016\/j.thromres.2025.109256_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102235","article-title":"D-dimer predicts venous thromboembolism in multiple myeloma: a nested case-control study","volume":"7","author":"Sanfilippo","year":"2023","journal-title":"Res Pract Thromb Haemost."},{"key":"10.1016\/j.thromres.2025.109256_bb0205","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.thromres.2023.12.004","article-title":"Low factor XIII levels and altered fibrinolysis in patients with multiple myeloma","volume":"234","author":"Ghansah","year":"2024","journal-title":"Thromb. Res."},{"issue":"12","key":"10.1016\/j.thromres.2025.109256_bb0210","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J. Clin. Epidemiol."},{"issue":"182","key":"10.1016\/j.thromres.2025.109256_bb0215","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.thromres.2019.07.011","article-title":"Increasing the sensitivity of the human microvesicle tissue factor activity assay","author":"Vallier","year":"2019","journal-title":"Thromb. Res."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825000052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825000052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:26:26Z","timestamp":1777472786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825000052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":43,"alternative-id":["S0049384825000052"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109256","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tissue factor-bearing extracellular vesicles, procoagulant phospholipids and D-dimer as potential biomarkers for venous thromboembolism in patients with newly diagnosed multiple myeloma: A comprehensive analysis","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109256"}}